Company Lipum AB

LIPUM

SE0015660899

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Annual profits - Rate of surprise

Sector Biopharmaceuticals

Delayed Nasdaq Stockholm Other stock markets 08:37:57 03/06/2024 BST			5-day change	1st Jan Change
6.6 ^SEK	-3.65%		+4.76%	+1.23%

05-06	Lipum Obtains SEK20 Million Loan from Flerie Invest	MT
04-02	Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer	CI

Lipum AB (publ) is a Sweden-based biopharmaceutical company specialized in discovery and development of new treatment for chronic inflammatory diseases. Lipum develops new biological medicine for treatment of chronic inflammatory diseases eg rheumatoid arthritis. Development is based on results from preclinical research, for example in well-established animal models for inflammatory arthritis. The prospective drug is an antibody directed against a new target molecule, the protein Bile Salt-Stimulated Lipase (BSSL). Lipum's antibody (SOL-116) has a different mechanism of action than the other drugs. Lipum's drug candidate SOL-116 is a humanized monoclonal antibody and is therefore categorized as a biological drug.

Number of employees: 5

Managers	Title	Age	Since
Ola Sandborgh CEO	Chief Executive Officer	-	11-30
Susanne Eva Lindqvist FOU	Founder	64	16/06/10
Olle Carl Hernell FOU	Founder	79	16/06/10
Sonja Marina Norberg DFI	Director of Finance/CFO	60	31/12/20
Pernilla Abrahamsson COO	Chief Operating Officer	52	31/12/18
Einar Pontén PRN	Corporate Officer/Principal	63	31/12/15

Members of the board	Title	Age	Since
Gustav Ingemar Kihlström BRD	Director/Board Member	71	31/12/20
Carl-Johan Spak BRD	Director/Board Member	68	31/12/22
Kristian Sandberg BRD	Director/Board Member	-	31/12/18
Åsa Kristina Hansdotter BRD	Director/Board Member	50	31/12/20
Ulf Björklund CHM	Chairman	68	31/12/15
Olle Carl Hernell FOU	Founder	79	16/06/10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	37,258,740	16,710,531 ( 44.85 %)	0	44.85 %

Lipum AB

Tvistevägen 48C

907 36, Umeå

+46 9 03 40 34 30

http://www.lipum.se

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
LIPUM AB	+1.23%	13.79M
CSL LIMITED	-1.85%	89.87B
SAMSUNG BIOLOGICS CO.,LTD.	-3.95%	37.57B
UCB	+61.85%	26.47B
BIOMARIN PHARMACEUTICAL INC.	-22.14%	14.25B
INCYTE CORPORATION	-7.96%	12.99B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.33%	11.93B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-46.33%	10.84B
SWEDISH ORPHAN BIOVITRUM AB	+4.12%	9.11B
INNOVENT BIOLOGICS, INC.	-19.53%	7.32B

Biopharmaceuticals